by Marie Daghlian | Apr 23, 2019 | Analysis, Deals
Analysis | Deals This article is a sample from the DealForma Quarterly Deal Trends Report provided to database subscribers. Data for the this analysis was compiled using the DealForma biopharma deals database. We applied initial filters for deals involving R&D and...
by Marie Daghlian | Jan 4, 2019 | Analysis, M&A
Analysis | M&A Data for the this analysis was compiled using the DealForma database on deals. We applied initial filters for mergers and acquisitions, target company types, therapeutic areas, company stage at acquisition, and deal payment terms. From there, we...
by Marie Daghlian | Dec 10, 2018 | Analysis, Deals
Analysis | Deals Data for the this analysis was compiled using the DealForma database on deals. We applied initial filters for deal types, therapeutic areas, stage at signing, and deal payment terms. From there, we exported the data to Excel and used pivot tables and...
by Marie Daghlian | Nov 27, 2018 | Analysis, Funding
Analysis | Funding Data for the this analysis was compiled using the DealForma database; specifically the companies and venture funding sections. We used company location data tagged with the three major U.S. biotech hubs along with primary therapeutic and technology...
![Biotech Companies in Major Industry Centers Rake in the Cash]()
by Marie Daghlian | Nov 10, 2018 | Analysis, Funding
Analysis | Funding Data for the this analysis was compiled using the DealForma database; specifically the companies and venture funding sections. We used company location data tagged with the three major U.S. biotech hubs along with primary therapeutic and technology...
